The cardiovascular effects of low-dose adrenomedullin (ADM, 1, 2 and 3 pmol
kg(-1) min(-1) for 30 min each) were evaluated in six healthy subjects in
a placebo controlled, cross-over study by determining cardiac volumes, syst
olic and diastolic function (echocardiography) and systemic haemodynamics b
efore, during and after ADM or placebo. High-resolution ultrasound was used
to evaluate changes in carotid artery distension. ADM caused a +85% increm
ent in its plasma levels and significantly increased plasma cyclic adenyl m
onophosphate (cAMP). Compared with placebo, ADM induced significant decreme
nts in left ventricular (LV) systolic diameter and systemic vascular resist
ance, and increments in LV posterior wall thickening, ejection fraction and
cardiac index. Right and left atrial emptying fraction and carotid artery
distention increased. LV diastolic function, heart rate, and plasma renin a
ctivity did not change, whereas packed cell volume increased. These results
indicate that ADM influences cardiovascular function and systemic haemodyn
amics at physiological plasma levels in man mainly because of its vasodilat
ing activity, leading to reduced afterload.